This inventor holds 1 USPTO granted patent and 9 published patent applications and 2 EPO patents. Top assignees: Beigene, Ltd., Springworks Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 54 
1 out of 49 Years Active: 2026
Title: Badreddin Edris: Innovator in Cancer Treatment
Introduction
Badreddin Edris is a notable inventor based in Stamford, CT (US). He has made significant contributions to the field of cancer treatment through his innovative research and patent work. His dedication to improving patient outcomes is evident in his patented methods and compositions.
Latest Patents
Edris holds a patent for the co-administration of mirdametinib and lifirafenib for use in treating cancers. The patent outlines methods for treating cancers that involve the coadministration of mirdametinib or a pharmaceutically acceptable salt form thereof, along with lifirafenib or a pharmaceutically acceptable salt form thereof, to patients in need. Additionally, the patent includes pharmaceutical compositions of these compounds for cancer treatment and their uses in the manufacture of medicaments.
Career Highlights
Throughout his career, Badreddin Edris has worked with prominent companies in the pharmaceutical industry, including BeiGene, Ltd. and SpringWorks Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Edris has collaborated with notable colleagues such as Zhiyu Tang and Lusong Luo. These partnerships have further enhanced his research and development efforts in cancer treatment.
Conclusion
Badreddin Edris is a dedicated inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative approaches and collaborations highlight his commitment to advancing medical science.